Cognoptix

Cognoptix is a pioneering company focused on developing a non-invasive beta amyloid eye scanning test for the early detection and diagnosis of Alzheimer's Disease. Their innovative Sapphire II system allows for a simple eye scan that can be performed in a doctor's office, addressing the significant unmet need for accurate and cost-effective diagnos... tic methods. Co-founded by Dr. Lee Goldstein and Dr. Leo Chylack, the company aims to empower physicians and patients in managing cognitive health through early intervention. Cognoptix is actively forming strategic alliances with pharmaceutical partners and academic institutions to advance its diagnostic platform for clinical use.Read More